A series of research have proved that FGFR1 was amplified in more than 10% of non-small cell lung cancers, and FGFR1-mediated signals pathway contribute to the growth, survival, and migration of NSCLC cells [8, 9, 32, 33]. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.